ReviewDrugs2014
A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program.
Miguel O'Ryan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
80 papers cite itlatest 60 shown
this paperpooled ittrialcites it